Evidence map›Paper›PMID 36295354›Full record

ReviewMaterials (Basel, Switzerland)2022

Materials Perspectives of Integrated Plasmonic Biosensors.

Ayman Negm, Matiar M R Howlader, Ilya Belyakov, Mohamed Bakr, Shirook Ali, Mehrdad Irannejad, Mustafa Yavuz

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ayman NegmDepartment of Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4K1, Canada.ORCID 0000-0003-3123-8962
Matiar M R HowladerDepartment of Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4K1, Canada.ORCID 0000-0001-8423-0791
Ilya BelyakovWaterloo Institute for Nanotechnology, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
Mohamed BakrDepartment of Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4K1, Canada.
Shirook AliDepartment of Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4K1, Canada.
Mehrdad IrannejadOZ Optics Ltd., Ottawa, ON K0A 1L0, Canada.
Mustafa YavuzWaterloo Institute for Nanotechnology, University of Waterloo, Waterloo, ON N2L 3G1, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the growing need for portable, compact, low-cost, and efficient biosensors, plasmonic materials hold the promise to meet this need owing to their label-free sensitivity and deep light-matter interaction that can go beyond the diffraction limit of light. In this review, we shed light on the main physical aspects of plasmonic interactions, highlight mainstream and future plasmonic materials including their merits and shortcomings, describe the backbone substrates for building plasmonic biosensors, and conclude with a brief discussion of the factors affecting plasmonic biosensing mechanisms. To do so, we first observe that 2D materials such as graphene and transition metal dichalcogenides play a major role in enhancing the sensitivity of nanoparticle-based plasmonic biosensors. Then, we identify that titanium nitride is a promising candidate for integrated applications with performance comparable to that of gold. Our study highlights the emerging role of polymer substrates in the design of future wearable and point-of-care devices. Finally, we summarize some technical and economic challenges that should be addressed for the mass adoption of plasmonic biosensors. We believe this review will be a guide in advancing the implementation of plasmonics-based integrated biosensors.

Indexed as

2D nanomaterialsgrapheneLSPRplasmonic biosensingplasmonic materialsplasmonicsplasmon resonancepoint-of-care devicesSPRsubstratesTMD

Identifiers

PMID36295354
PMCPMC9611134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.